- Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
- Toxic Lead Found in Cinnamon Product, FDA Says
- Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
- Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
- Fake Oxycontin Pills Widespread and Potentially Deadly: Report
- Shingles Vaccine Could Lower Dementia Risk
- Your Odds for Accidental Gun Death Rise Greatly in Certain States
- Kids From Poorer Families Less Likely to Survive Cancer
- Tough Workouts Won’t Trigger Cardiac Arrest in Folks With Long QT Syndrome
- At-Home Colon Cancer Test Can Save Lives
Gardasil Approved for Additional Types of HPV
![](https://ladylively.com/wp-content/uploads/2013/08/skin-care1-300x336.jpg)
The Gardasil 9 vaccine has been approved by the U.S. Food and Drug Administration to treat five additional types of Human Papillomavirus (HPV), the virus that can lead to several forms of cancer, including that of the cervix, the FDA said Wednesday.
The approval covers females ages 9 through 26 and males ages 9 through 15, the agency said in a news release. The additional types of HPV — 31, 33, 45, 52 and 58 — cause about 20 percent of cervical cancers and weren’t covered by prior approvals of Gardasil.
HPV also can lead to vulvar, vaginal and anal cancers, and genital warts. Prior Gardasil approvals covered HPV types 16, 18, 31, 33, 45, 52 and 68, the FDA said.
Gardasil 9 is given as three separate shots within six months. The most common side effects reported during clinical evaluation included injection-site pain, swelling, redness and headache.
The vaccine is manufactured by Merck, based in Whitehouse Station, N.J.
More information
Visit the FDA to learn more.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.